TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16178704

Group type: EXPERIMENTAL
Intervention: HIV prevention program for couples
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention pilot study (Phase 2)
Number of subjects: 0
Study: 12566473

Group type: EXPERIMENTAL
Intervention: +OC
Number of subjects: 30

Group type: COMPARATOR
Intervention: -OC
Number of subjects: 30
Study: 10573727

Group type: EXPERIMENTAL
Intervention: Sulbutiamine 600 mg daily
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Sulbutiamine 400 mg daily
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 9279680

Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified (HSM) PMMA intraocular lenses
Number of subjects: 99

Group type: COMPARATOR
Intervention: Unmodified PMMA intraocular lenses
Number of subjects: 99
Study: 1948264

Group type: EXPERIMENTAL
Intervention: Proguanil (200 mg/day) combined with sulfamethoxazole (1000 mg/day)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Proguanil (200 mg/day) combined with sulfamethoxazole (1500 mg/day)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Proguanil/sulfamethoxazole
Number of subjects: 383

Group type: COMPARATOR
Intervention: Pyrimethamine/dapsone (Maloprim)
Number of subjects: 383
Study: 6341724

Group type: EXPERIMENTAL
Intervention: Computer-generated reminders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard follow-up without reminders
Number of subjects: 0
Study: 31146022

Group type: EXPERIMENTAL
Intervention: Exercise intervention offered to patients (n = 130)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group (n = 130)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: TwiCs design
Number of subjects: 260
Study: 27771617

Group type: EXPERIMENTAL
Intervention: Supervising for Home Safety (SHS) program
Number of subjects: 95

Group type: COMPARATOR
Intervention: Attention-matched control program
Number of subjects: 95
Study: 25778685

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (2000 IU/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Alfacalcidol (0.5 μg/day)
Number of subjects: 36
Study: 23435693

Group type: EXPERIMENTAL
Intervention: GlideScope video laryngoscope
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Truview PCD video laryngoscope
Number of subjects: 134

Group type: COMPARATOR
Intervention: Direct laryngoscopy (Macintosh blade)
Number of subjects: 134
Study: 21161329

Group type: EXPERIMENTAL
Intervention: Preemptive warfarin dose reduction (10-20%)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Reactive warfarin dose adjustment
Number of subjects: 37
Study: 19524987

Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block and intraprostatic local anesthesia with 5 ml 2% lidocaine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Periprostatic nerve block with 0.9% NaCl by intraprostatic injection
Number of subjects: 300

Group type: COMPARATOR
Intervention: No anesthesia
Number of subjects: 300
Study: 15663579

Group type: EXPERIMENTAL
Intervention: CTG abnormalities in fetuses with metabolic acidaemia
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: ST segment abnormalities in fetuses with metabolic acidaemia
Number of subjects: 142

Group type: COMPARATOR
Intervention: CTG abnormalities in controls
Number of subjects: 142

Group type: COMPARATOR
Intervention: ST segment abnormalities in controls
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Indication for intervention based on CTG in cases with acidaemia
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Indication for intervention based on CTG + ST in cases with acidaemia
Number of subjects: 142

Group type: COMPARATOR
Intervention: Indication for intervention based on CTG in controls
Number of subjects: 142

Group type: COMPARATOR
Intervention: Indication for intervention based on CTG + ST in controls
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement for ST abnormalities
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement for CTG abnormalities
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement for indication to intervene based on CTG + ST
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement for indication to intervene based on CTG alone
Number of subjects: 142
Study: 12578443

Group type: EXPERIMENTAL
Intervention: Adenoidectomy with tympanostomy
Number of subjects: 306

Group type: COMPARATOR
Intervention: Tympanostomy only (Control)
Number of subjects: 306
Study: 10522590

Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Granisetron (3 mg)
Number of subjects: 80
Study: 8886862

Group type: EXPERIMENTAL
Intervention: Bradykinin 300 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bradykinin 100 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bradykinin 300-1000 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bradykinin 1000 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bradykinin 300 micrograms or 1000 micrograms
Number of subjects: 0
Study: 1792613

Group type: EXPERIMENTAL
Intervention: Nadolol (N)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Propranolol (PP)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Prazosin (PS)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Diuretic (D)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Combined therapy (2-3 drugs)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 419
Study: 6349944

Group type: EXPERIMENTAL
Intervention: Broad-spectrum sunscreen agent
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 53
Study: 30712444

Group type: EXPERIMENTAL
Intervention: One-session cognitive behavior treatment (CBT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 30396331

Group type: EXPERIMENTAL
Intervention: Standardised questionnaires and tests for clinical, neuropsychological, behavioural and health-economic assessments.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative study exploring health care needs and experiences of patients and carers.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventional sub-study evaluating impact of specialist recommendations.
Number of subjects: 0
Study: 27197690

Group type: EXPERIMENTAL
Intervention: Rituximab (1 g intravenous on days 1 and 15, and after 26 weeks if needed)
Number of subjects: 295

Group type: COMPARATOR
Intervention: TNF inhibitor (adalimumab 40 mg subcutaneously every other week or etanercept 50 mg per week subcutaneously)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 295

Group type: COMPARATOR
Intervention: TNF inhibitor
Number of subjects: 295
Study: 24317854

Group type: EXPERIMENTAL
Intervention: Vitrification (Irvine method)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Vitrification (Vitrolife method)
Number of subjects: 568

Group type: COMPARATOR
Intervention: Slow freezing
Number of subjects: 568
Study: 22045836

Group type: EXPERIMENTAL
Intervention: Adalimumab plus MTX
Number of subjects: 799

Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 799

Group type: COMPARATOR
Intervention: Adalimumab monotherapy
Number of subjects: 799
Study: 19382479

Group type: EXPERIMENTAL
Intervention: Lianhuang Decoction (LHD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 60
Study: 17369792

Group type: EXPERIMENTAL
Intervention: Once per week leg press exercise (n=10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Twice per week leg press exercise (n=11)
Number of subjects: 21
Study: 16311972

Group type: EXPERIMENTAL
Intervention: Perfused arteries
Number of subjects: 32

Group type: COMPARATOR
Intervention: Clipped arteries
Number of subjects: 32
Study: 12042579

Group type: EXPERIMENTAL
Intervention: Early postnatal dexamethasone (0.5 mg/kg/d for the first 3 days, 0.25 mg/kg/d for the next 3 days, and 0.125 mg/kg/d on the seventh day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (untreated neonates)
Number of subjects: 50
Study: 9856295

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 8522734

Group type: EXPERIMENTAL
Intervention: Peripheral sympathectomy
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (n = 7 extremities)
Number of subjects: 7
Study: 2087938

Group type: EXPERIMENTAL
Intervention: sucrose diet (30 g/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: control diet (high-carbohydrate high-fiber diet)
Number of subjects: 12
Study: 23136

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg orally
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg orally
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Propranolol 0.2 mg/kg intravenously
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Metoprolol 0.2 mg/kg intravenously
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Oxprenolol 80 mg orally
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Oxprenolol 0.2 mg/kg intravenously
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Practolol 200 mg orally
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Practolol 1 mg/kg intravenously
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pindolol 0.05 mg/kg intravenously
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: All active treatments
Number of subjects: 2
Study: 31410966

Group type: EXPERIMENTAL
Intervention: Condom-catheter uterine balloon tamponade (UBT) introduced after training and provision of kits.
Number of subjects: 28183

Group type: COMPARATOR
Intervention: Control period (before UBT introduction).
Number of subjects: 28183
Study: 29267567

Group type: COMPARATOR
Intervention: Traditional upper blepharoplasty with a single running suture skin closure
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Upper blepharoplasty with brassiere sutures (orbicularis oculi muscle fixation to the periosteum)
Number of subjects: 50
Study: 26358523

Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trastuzumab with chemotherapy
Number of subjects: 0
Study: 23596888

Group type: EXPERIMENTAL
Intervention: Safflower peony ointment single dosage scheme (2.16 g, 4 people; 4.32 g, 6 people; 6.48 g, 6 people; 8.62 g, 6 people; 11.46 g, 6 people; 15.24 g, 6 people) for 24 hours, once every day.
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Safflower peony ointment multi-dosage scheme (8.62 g, 6 people; 11.46 g, 6 people) once every day for 7 days.
Number of subjects: 46
Study: 21539525

Group type: EXPERIMENTAL
Intervention: Low Drug Burden Index (DBI <1)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: High Drug Burden Index (DBI ≥1)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Low Drug Burden Index (DBI <1) after adjustment
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: High Drug Burden Index (DBI ≥1) after adjustment
Number of subjects: 602
Study: 19536689

Group type: EXPERIMENTAL
Intervention: Handgun with female perpetrator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folding knife with female perpetrator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Knitting needle with female perpetrator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folding knife with male perpetrator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dangerous perception of perpetrators (both genders)
Number of subjects: 0
Study: 16829772

Group type: EXPERIMENTAL
Intervention: Nursing interventions for smoking cessation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tobacco cessation interventions
Number of subjects: 0
Study: 12162857

Group type: EXPERIMENTAL
Intervention: Intravenous doxepin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral doxepin
Number of subjects: 12
Study: 10550137

Group type: EXPERIMENTAL
Intervention: GM-CSF priming
Number of subjects: 20
Study: 7800338

Group type: EXPERIMENTAL
Intervention: IFO 2.5 g/m2 days 1‐2 + EPI 70 mg/m2 day 1 + cisplatin (DDP) 70 mg/m2 day 1 (arm IEP)
Number of subjects: 203

Group type: COMPARATOR
Intervention: IFO 2.5 g/m2 days 1‐2 + EPI 70 mg/m2 day 1 (arm IE)
Number of subjects: 203
Study: 2349954

Group type: EXPERIMENTAL
Intervention: Oral L-carnitine supplementation, 100 mg/kg/day for 2 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no oral L-carnitine supplementation)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 12
Study: 159841

Group type: EXPERIMENTAL
Intervention: Ro 11‐1430 (0.1% vanishing cream)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (vanishing cream alone)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Ro 11‐1430
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 29603005

Group type: EXPERIMENTAL
Intervention: 3D/HD monitor
Number of subjects: 11

Group type: COMPARATOR
Intervention: 2D/4K monitor
Number of subjects: 11

Group type: COMPARATOR
Intervention: 2D/HD monitor
Number of subjects: 11
Study: 25715022

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube
Number of subjects: 50

Group type: COMPARATOR
Intervention: Endotracheal tubes
Number of subjects: 50
Study: 25594845

Group type: EXPERIMENTAL
Intervention: Barrier-improving cream (5% urea)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference cream
Number of subjects: 0
Study: 24076337

Group type: EXPERIMENTAL
Intervention: 25% albumin (2 g/kg; maximum dose 750 mL)
Number of subjects: 841

Group type: COMPARATOR
Intervention: Isotonic saline (equivalent volume)
Number of subjects: 841
Study: 20677054

Group type: EXPERIMENTAL
Intervention: Pictographs
Number of subjects: 4685

Group type: COMPARATOR
Intervention: Text and Tables
Number of subjects: 4685
Study: 18534594

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg dose)
Number of subjects: 122
Study: 17038253

Group type: EXPERIMENTAL
Intervention: Glutamine + TPN (0.27 g.kg(‐1).d(‐1) for 7 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine TPN
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Glutamine + TPN
Number of subjects: 40
Study: 12201967

Group type: EXPERIMENTAL
Intervention: Clinical Decision Strategy (CDS)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Surgical strategy (Euro-S)
Number of subjects: 362
Study: 9708223

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 23
Study: 8543875

Group type: EXPERIMENTAL
Intervention: Two-portal endoscopic release
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional palmar open release
Number of subjects: 96
Study: 2223274

Group type: EXPERIMENTAL
Intervention: Counseling program
Number of subjects: 2489

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2489
Study: 153716

Group type: EXPERIMENTAL
Intervention: EMG-biofeedback from abdominal muscles
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EMG-biofeedback from frontalis muscles
Number of subjects: 12

Group type: COMPARATOR
Intervention: No EMG treatment (control group)
Number of subjects: 12
Study: 31416011

Group type: EXPERIMENTAL
Intervention: SSS07 (5 mg, 15 mg, 30 mg, 50 mg, 75 mg, 100 mg)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: SSS07 (5 mg to 100 mg)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: SSS07
Number of subjects: 71
Study: 28901534

Group type: EXPERIMENTAL
Intervention: Oral isotretinoin (0.5 mg/kg/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical isotretinoin (0.05% gel, once daily at night)
Number of subjects: 40
Study: 26277764

Group type: EXPERIMENTAL
Intervention: CRT-ON
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 0

Group type: COMPARATOR
Intervention: NYHA functional class II
Number of subjects: 0
Study: 24867353

Group type: EXPERIMENTAL
Intervention: 80 hours (16 weeks) of cognitive training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Computer games control condition
Number of subjects: 30
Study: 22546262

Group type: EXPERIMENTAL
Intervention: Serving fruits and vegetables in advance of other menu items (0.40 servings/meal)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Provider portioned meals
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional family style meal service (control)
Number of subjects: 53
Study: 18574608

Group type: EXPERIMENTAL
Intervention: Polytherapy with two atypical antipsychotics
Number of subjects: 364

Group type: COMPARATOR
Intervention: Monotherapy with atypical antipsychotics
Number of subjects: 364
Study: 17301646

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg once daily
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 1303
Study: 15064101

Group type: EXPERIMENTAL
Intervention: Soy protein
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isoflavones
Number of subjects: 20

Group type: COMPARATOR
Intervention: Animal protein
Number of subjects: 20
Study: 11966543

Group type: COMPARATOR
Intervention: Conventional treatment (acid decreasing therapy with H2-receptor antagonist or PPI)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Dual therapy (one antibiotic plus acid-decreasing therapy)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Triple therapy (PPI plus amoxicillin and clarithromycin)
Number of subjects: 445
Study: 9709461

Group type: EXPERIMENTAL
Intervention: Immediate AZT monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deferred AZT monotherapy
Number of subjects: 0
Study: 8620950

Group type: EXPERIMENTAL
Intervention: Low-dose salbutamol metered-dose inhaler (50 micrograms.puff-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard dose salbutamol metered-dose inhaler (100 micrograms.puff-1)
Number of subjects: 20
Study: 28964720

Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention (group-based, behavioral weight-loss program led by community health workers)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Enhanced usual care condition (dietary counseling and written materials)
Number of subjects: 301
Study: 25249408

Group type: EXPERIMENTAL
Intervention: Social threat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cortisol response to the stressor
Number of subjects: 0
Study: 25394818

Group type: EXPERIMENTAL
Intervention: PC6 acupoint stimulation using acupressure wristbands for 36 hours
Number of subjects: 712

Group type: COMPARATOR
Intervention: Placebo wristbands
Number of subjects: 712
Study: 23723250

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 9033

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 9033
Study: 20493771

Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg/day)
Number of subjects: 889

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 889
Study: 19348656

Group type: EXPERIMENTAL
Intervention: Etanercept treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (patients with inflammatory skin diseases)
Number of subjects: 22
Study: 17679954

Group type: EXPERIMENTAL
Intervention: Perftoran infusions with basic therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Basic conservative therapy (control group)
Number of subjects: 85
Study: 15067650

Group type: EXPERIMENTAL
Intervention: Posterior Stabilized (PS) TKA
Number of subjects: 20

Group type: COMPARATOR
Intervention: Posterior Cruciate-Retaining (PCR) TKA
Number of subjects: 20
Study: 11130216

Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg once/day for the first week, 20 mg once/day for the second week, and 40 mg once/day for the remaining 3 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 32
Study: 9050976

Group type: EXPERIMENTAL
Intervention: 0.2 mg moxonidine once a day (increased to 0.4 mg after 2 weeks)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 5 mg enalapril once a day (increased to 10 mg after 2 weeks)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 8319334

Group type: EXPERIMENTAL
Intervention: Colestipol-niacin therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 3539617

Group type: EXPERIMENTAL
Intervention: Sotalol administered over 12 hours by continuous infusion at three different rates
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 20
Study: 30325784

Group type: EXPERIMENTAL
Intervention: Transurethral catheter removal 6 hours postoperative
Number of subjects: 88

Group type: COMPARATOR
Intervention: Transurethral catheter removal the morning following surgery (control group)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (morning following surgery)
Number of subjects: 88
Study: 29948418

Group type: EXPERIMENTAL
Intervention: TachoSil® patches
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group (no TachoSil®)
Number of subjects: 142
Study: 27560495

Group type: EXPERIMENTAL
Intervention: Maternal triglycerides in late pregnancy
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Cord blood triglycerides
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Cord HDL‐C
Number of subjects: 331
Study: 23905590

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Behaviour Therapy (BT)
Number of subjects: 30
Study: 22086903

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (n = 20), 40 minutes of gait training with Lokomat and 60 minutes of conventional physical therapy daily.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional physical therapy (n = 17), 100 minutes of conventional physical therapy daily.
Number of subjects: 37
Study: 20592268

Group type: EXPERIMENTAL
Intervention: Upper-limb exercise with caregiver support
Number of subjects: 50

Group type: COMPARATOR
Intervention: Upper-limb exercise without caregiver support
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Caregiver support
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fugl-Meyer score and treatment intensity
Number of subjects: 50
Study: 17917464

Group type: EXPERIMENTAL
Intervention: Bladder training alone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Propiverine combined with bladder training
Number of subjects: 48